"Extrauterine growth restriction" and "postnatal growth failure" are misnomers for preterm infants

Tanis R Fenton1,2, Barbara Cormack3, Dena Goldberg4

  • 1Community Health Sciences, Institute of Public Health, Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada. tfenton@ucalgary.ca.

Insights

Extrauterine growth restriction (EUGR) and postnatal growth failure (PGF) in preterm infants are often diagnosed using unhelpful weight-based cutoffs. These diagnoses lack predictive value and do not account for individual growth potential or body composition.

Area of Science:

  • Neonatology
  • Pediatric Growth and Development
  • Nutritional Science

Background:

  • Extrauterine growth restriction (EUGR) and postnatal growth failure (PGF) are common concerns in preterm infants.
  • Current diagnostic criteria often rely on arbitrary weight percentiles (<10th) at discharge or 36-40 weeks postmenstrual age.
  • These labels are frequently applied without considering head circumference, length, proportionality, body composition, or genetic growth potential.

Purpose of the Study:

  • To critically evaluate the limitations of current definitions of EUGR/PGF in preterm neonates.
  • To highlight the challenges posed by arbitrary statistical cut-offs in growth assessment.
  • To explore opportunities for refining the understanding of growth and nutritional requirements in this population.

Main Methods:

  • Review of current diagnostic practices for EUGR/PGF.
  • Analysis of the shortcomings of weight-only percentile-based assessments.
  • Discussion of the implications of arbitrary cut-offs on nutritional management.

Main Results:

  • EUGR/PGF diagnoses based on current criteria are not predictive of adverse outcomes.
  • These diagnoses neglect crucial growth parameters like head and length growth, proportionality, and body composition.
  • Assessment timing often precedes natural fetal growth deceleration, leading to potentially inaccurate classifications.
  • Normal postnatal weight loss is frequently ignored in these assessments.

Conclusions:

  • The current definitions of EUGR/PGF are oversimplified and lack clinical utility.
  • Arbitrary growth cut-offs can lead to misclassification and potentially inappropriate nutritional interventions.
  • Further research is needed to develop more comprehensive and individualized approaches to assessing preterm infant growth and nutritional needs.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.0K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
633
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K
Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
1.2K